The growing trend for personalized medicines is driving market growth.New York, USA, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Market ...

总之，本研究提出了一种开创性的方法，通过基于转录组学的液体活检组合，早期检测局部进展期胃癌的复发。与传统的临床模型或单一生物标志物方法相比，将4-mRNA组合与临床特征相结合的RSA模型显示出更好的预测性能。尽管有一定的局限性，但本研究代表了液体活检 ...

colorectal (colon) cancer; epidermal growth factor receptor (EGFR); RAS; liquid biopsy; rechallenge; cetuximab; RAS; ...

We speak to Morghan Lucas (MGZ, Munich) about emerging omics, cancer diagnostics her experience at the Festival of Genomics ...

In a significant advancement for cancer prevention and care the Abu Dhabi Public Health Centre ADPHC in partnership with M42 ...

Cancer, one of the most life-threatening diseases, is projected to affect over 35 million people worldwide in 2050 — 77% more ...

Abu Dhabi Public Health Centre (ADPHC), in partnership with M42, has introduced a non-invasive blood-based cancer screening ...

Guardant Health, Inc. (GH) is poised for long-term growth as its revenue projections and R&D spending paint a growth story ...

A federal court jury has sided with Guardant Health, which had claimed that rival cancer test developer Natera went too far ...

Today marks two years since WTOP’s Neal Augenstein was diagnosed with stage 4 lung cancer. He reflects on where he’s been in ...